@prefix biolink: <
https://w3id.org/biolink/vocab/
> .
@prefix dcterms: <
http://purl.org/dc/terms/
> .
@prefix this: <
http://purl.org/np/RAdzZfNP3FR9iEtT0sOp4die14iSu2iU8pUU8efN5VJeA
> .
@prefix sub: <
http://purl.org/np/RAdzZfNP3FR9iEtT0sOp4die14iSu2iU8pUU8efN5VJeA#
> .
@prefix np: <
http://www.nanopub.org/nschema#
> .
@prefix rdf: <
http://www.w3.org/1999/02/22-rdf-syntax-ns#
> .
@prefix nt: <
https://w3id.org/np/o/ntemplate/
> .
@prefix xsd: <
http://www.w3.org/2001/XMLSchema#
> .
@prefix rdfs: <
http://www.w3.org/2000/01/rdf-schema#
> .
@prefix orcid: <
https://orcid.org/
> .
@prefix nkg: <
https://w3id.org/um/neurodkg/
> .
@prefix prov: <
http://www.w3.org/ns/prov#
> .
@prefix npx: <
http://purl.org/nanopub/x/
> .
sub:Head
{
this:
np:hasAssertion
sub:assertion
;
np:hasProvenance
sub:provenance
;
np:hasPublicationInfo
sub:pubinfo
;
a
np:Nanopublication
.
}
sub:assertion
{
sub:association
rdf:object
<
https://identifiers.org/MONDO:0001945
> ;
rdf:predicate
biolink:treats
;
rdf:subject
<
https://identifiers.org/CHEBI:3182
> ;
a
rdf:Statement
;
rdfs:label
"Bromocriptine mesylate tablets are indicated in the treatment of the signs and symptoms of idiopathic or postencephalitic Parkinson's disease. As adjunctive treatment to levodopa (alone or with a peripheral decarboxylase inhibitor), bromocriptine mesylate therapy may provide additional therapeutic benefits in those patients who are currently maintained on optimal dosages of levodopa, those who are beginning to deteriorate (develop tolerance) to levodopa therapy, and those who are experiencing \"end of dose failure\" on levodopa therapy." ;
biolink:association_type
biolink:ChemicalToDiseaseOrPhenotypicFeatureAssociation
;
biolink:provided_by
"NeuroDKG" ;
biolink:publications
<
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=93a0696b-b261-4262-9e06-f3180b419f8f
> ;
biolink:relation
nkg:SymptomaticReliefIndication
.
<
https://identifiers.org/CHEBI:3182
>
biolink:category
biolink:Drug
.
<
https://identifiers.org/MONDO:0001945
>
biolink:category
biolink:Disease
.
}
sub:provenance
{
sub:assertion
prov:wasAttributedTo
orcid:0000-0002-1468-3557
.
}
sub:pubinfo
{
sub:sig
npx:hasAlgorithm
"RSA" ;
npx:hasPublicKey
"MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" ;
npx:hasSignature
"ZHyrCk2z7qXvlzKEAzZQfFVAnc2w0z+nW4bse6zUIMp2SCax3AqnRRlqQAiORr37W9rnr7DwxLMi3HdsOIbMa9rtLKEFBUBQYiwXmG70Yy80Yp5o/9oJG1YUSL7QfmuLA5OWq3UOgreM1u11v6GYXMi6oEy5HV1cadB6O59EgC0=" ;
npx:hasSignatureTarget
this:
.
this:
dcterms:created
"2021-03-28T20:10:59.894+02:00"^^
xsd:dateTime
;
dcterms:creator
orcid:0000-0002-1468-3557
;
nt:wasCreatedFromProvenanceTemplate
<
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
> ;
nt:wasCreatedFromPubinfoTemplate
<
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
> ;
nt:wasCreatedFromTemplate
<
http://purl.org/np/RA59AEpaWRaR9sjdA0-n4zaQWdiZ6--iGafMrjrDAOheI
> .
}